REG - Smiths Group PLC - Director Responsibilities

SmithsAnnouncement

01/02/2022 14:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220201:nRSA3415Aa&default-theme=true

RNS Number : 3415A  Smiths Group PLC  01 February 2022

1 February 2022

 

SMITHS GROUP PLC ("Smiths")

DIRECTOR RESPONSIBILITIES

 

In accordance with the terms of the shareholders agreement entered into with
ICU Medical, Inc. ('ICU') on the sale of Smiths Medical, Smiths is pleased to
announce that Bill Seeger, a non-executive Director of Smiths, will join the
ICU Board and Audit and Compliance Committee as Smiths' nominee with effect
from 1 February 2022. Bill Seeger's ongoing appointment will be subject to ICU
shareholder approval at each annual ICU shareholder meeting.

 

Bill Seeger will not receive a fee from Smiths or ICU for his role as an ICU
Director or Audit and Compliance Committee member. Biographic details can be
found on Smiths' website www.smiths.com (http://www.smiths.com) .

 

There is no further information required to be disclosed pursuant to LR
9.6.11(3) or LR9.6.14(2).

Enquiries:

 

Matthew Whyte

Group Company Secretary

+44 (0) 20 7004 1600

+44 (0) 7775 982 879

Matthew.whyte@smiths.com (mailto:Matthew.whyte@smiths.com)

 

Jemma Spalton

Investor Relations Director

+44 (0) 20 7004 1600

+44 (0) 7867 390 350

Jemma.spalton@smiths.com (mailto:Jemma.spalton@smiths.com)

 

Legal Entity Identifier (LEI): 213800MJL6IPZS3ASA11

 

About Smiths Group

For over 170 years, Smiths Group has been pioneering progress by improving the
world through smarter engineering. We serve millions of people every year, to
help create a safer, more efficient and better-connected world, across four
major global markets:  Energy, General Industry, Security & Defence, and
Aerospace. Listed on the London Stock Exchange, Smiths employs c.14,600
colleagues in over 50 countries. For more information visit www.smiths.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCUARURUKUURAR